Health IT

With changing healthcare dynamics such as the increasing average age of patients, a less healthy society, increased demand for tests and decreased funding, many laboratories are feeling the impact. One area where this impact is highlighted relates to the use of pathology to control chronic disease.

Compact haematology analyser

The burden of chronic disease is increasing rapidly in our populations. This in turn drives an increase in pathology testing. Are more tests being ordered because there is not enough information about how test results should best be interpreted? Can clinicians pick a true change in test results, and therefore clinically significant patterns? The answer to these questions indicated information available at the point of test ordering is insufficient and there are gaps in the interpretation of patient lab reports.

Using HBA1C as an example, on average six monthly testing is unnecessary (Aronsen et al, NHS Diabetes). Providing better guidelines on intervals between testing will facilitate a change in the trend of over-ordering of lab tests.

How can labs provide better guidance; i.e. how often are tests needed? Can we guide testing intervals? What is a meaningful change in a test results?

How can value be added for patients, so that the pathology spend is measured in terms of patient care. Current health funding remains focused on treatment, the cost of hospitalisation dominates the health spend and pathology is often referred to as a “cost centre”.

The laboratory service can be utilised as a risk management strategy for health care outcomes by implementing the following initiatives:

  • Organise and use the lab data
  • Provide incentives to find chronic disease cases within the data
  • Establish constructive testing protocols
Compact haematology analyser

These initiatives together contribute to a patient-centric care model. Pathology testing is a valuable component of chronic disease management and healthcare needs to expand on the traditional methods of diagnosis, treatment, compliance monitoring and prognosis to novel and perhaps “disruptive” approaches.

  • Novel – create insight – use the LIS and linked databases to find the patients, based on social and geodemographics. Find insights and change strategies. Look at the data.
  • Disruptive – give patients the information in the right format and keep them well at home.

Laboratories are challenged to meet increasing demands on lab testing in parallel with the increase in patients with chronic disease:

  • Provide better guidance for recommended test ordering
  • Report patient centred results and guided interpretation which enables better management of disease by clinician and patient
  • Utilise data mining – find the trends in data, find and manage the patients, be proactive to help manage the chronic disease epidemic